Mounjaro®
Starting from £179.99/mo
Start journey Learn moreUK private prices for weight loss injections have risen sharply, not fallen. In September 2025, Eli Lilly raised its UK list price for Mounjaro substantially — the highest-strength pen moved from roughly £122 to around £330 — and private providers adjusted accordingly. Whether prices will fall again depends on factors like competition, supply and NHS commissioning decisions that no one can predict with certainty. These are prescription-only medicines; a clinician must assess your suitability before any treatment begins. Weight loss injections are not a retail product, and their pricing doesn't follow ordinary market logic.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The price surge for weight loss injections like Mounjaro and Wegovy in the UK wasn't random. Global demand for GLP-1 and dual-agonist medicines outstripped manufacturing capacity, and Eli Lilly's September 2025 list-price increase (widely reported at the time) formalised a cost that the private market had already been absorbing. Novo Nordisk's Wegovy had its own supply pressures. Prices across private providers typically range from roughly £149 to £375 per month depending on the dose and clinic, as reported across industry sources. These figures are hedged: they shift, they vary by provider, and they don't include what some clinics charge separately for consultations, prescriptions or follow-up support. If you're comparing quotes, the gap between a headline number and the actual monthly outlay can be significant. What drives differences between providers is worth reading before treating any single figure as a benchmark.
A price advertised per pen is rarely the whole picture. Across the private weight loss market, consultation fees vary from free to £80 or more. Prescription charges can be billed separately. Delivery fees, particularly for refrigerated medicines requiring a tracked cold-chain service, are sometimes added at checkout. Dose-review support (the clinical oversight that should accompany every step up in dose) is not universally included. Before any dose increase, a prescriber should check your progress and confirm it's appropriate; not every service treats that as part of the deal. The cheapest route to these medicines isn't always the one that looks cheapest at the top of a Google results page. Read the small print on what a price actually covers.
Three things could shift private prices downward: increased manufacturing capacity (both Lilly and Novo Nordisk have announced significant investment in production), new market entrants as patents mature and biosimilar development progresses, and NHS commissioning expanding enough to reduce demand on the private side. The NHS rollout of tirzepatide for weight management (phased by BMI and comorbidity thresholds under NICE's recommendation TA1026) is gradually expanding. As of June 2026, the second NHS cohort (BMI 35–39.9 with four or more qualifying conditions) began accessing treatment. Broader eligibility, when it arrives, may reduce the number of people who need to go private, and our guide on how to get weight loss injections cheap covers the practical steps worth taking in the meantime. Payday ordering habits and timing around public holidays do cause short-term demand spikes at some services, but they don't move underlying prices. None of this means prices will fall soon, or by how much. Anyone who tells you otherwise is guessing.
We are not the cheapest option, and we made that choice deliberately. A single transparent price covers the free consultation, the prescription reviewed by a clinician on our team, the medicine, and free next-working-day DPD delivery in plain packaging. The clinical oversight is built in: a real prescriber reviews every consultation the same day, not software, not a queue. Our aftercare is seven days a week, and every repeat order goes through another clinical review before anything is dispatched. You can read more about the thinking behind how we work on our about page. What we won't do is run discount codes or promotional pricing for a prescription medicine. That's not a marketing position. Discount codes on prescription-only medicines from unverified sellers are, per MHRA guidance, a red flag for counterfeit supply. The MHRA's Yellow Card scheme lets you report suspect sellers. Our pharmacy is GPhC-registered (registration 9012878, verifiable at the GPhC register), and medicines are sourced through the licensed UK supply chain. Price is the wrong test for a prescription medicine. The right questions are: is the pharmacy verified, is a qualified prescriber reviewing my case, and is the supply chain legitimate? Those questions have clear answers. If you'd like to understand more about what makes some weight loss injections cheaper than others, including the trade-offs involved, that's worth a read before making a decision. If you'd like to see what current treatment pricing includes, our treatment page has the full breakdown. We explore the broader picture of whether injection prices will fall separately, including what the biosimilar pipeline looks like for the UK. For a direct comparison of current providers, our breakdown of the cheapest place to get weight loss injections looks at what each option actually includes.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.